Clinical Trial Update: CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a GPC3-targeted CAR-T cell therapy for advanced GPC3-positive hepatocellular carcinoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• GPC3-targeted CAR-T cell therapy (GPC3-targeted CAR-T)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING